CDKN2A and neoplasm: SMAD4 deficiency also accelerated PDAC development in KrasG12D combined with INK4A/ARF heterozygous-loss mice and affected the histological type of PDAC with a more highly differentiated type, rather than a poor differentiate tumor [13].